MedTrace Logo

Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis

NCT06821802 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-07-10

No results posted yet for this study

Summary

The goal of this study is to assess the impact of protein supplementation on hyponatremia caused by the syndrome of inappropriate antidiuresis during hospitalization.

Conditions

Interventions

DIETARY_SUPPLEMENT

Moltein PURE Protein Powder

80 g protein supplementation per day (two bottles, each containing 40 g protein)

BEHAVIORAL

Fluid restriction

total daily fluid intake to a maximum of 1000 ml

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Mirjam Christ-Crain, Prof. MD · Universitätsspital Basel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-14
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06821802 on ClinicalTrials.gov